• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-92a 通过调控 KLF4/PI3K/AKT 通路抑制先天性巨结肠症神经细胞的活力和迁移。

miR‑92a represses the viability and migration of nerve cells in Hirschsprung's disease by regulating the KLF4/PI3K/AKT pathway.

机构信息

Department of General Surgery, Hunan Children's Hospital, Changsha, P.R. China.

Department of General Surgery, Hunan Children's Hospital, Changsha, P.R. China;

出版信息

Acta Neurobiol Exp (Wars). 2022;82(3):336-346. doi: 10.55782/ane-2022-032.

DOI:10.55782/ane-2022-032
PMID:36214716
Abstract

Hirschsprung's disease (HSCR) is an intestinal disease caused by defects in neural crest cell migration, proliferation, differentiation, and survival. Many reports have proposed that miRNA dysregulation is related to the occurrence of HSCR. However, the roles and mechanisms of miRNAs have not been thoroughly studied. The levels of miR‑92a and KLF4 were examined using qRT‑PCR and immunohistochemistry, respectively. Cell viability, migration and apoptosis were evaluated by MTT, Transwell and flow cytometry assays, respectively. A dual‑luciferase reporter assay was employed to verify the binding relationship between miR‑92a and KLF4. Levels of PI3K/AKT signals were further determined by western blot assay. Herein, elevated expression of miR‑92a and reduced expression of KLF4 were found in HSCR tissues, and their expression patterns were negatively correlated. Overexpression of miR‑92a inhibited cell viability and migration but enhanced cell apoptosis. However, overexpression of KLF4 had the opposite effects. Mechanistically, KLF4 was a target of miR‑92a and it negatively affected biological functions by activating PI3K/AKT signaling. These results proved that miR‑92a inhibited the proliferation and metastasis of nerve cells by regulating the KLF4/PI3K/AKT axis.

摘要

先天性巨结肠症(HSCR)是一种由神经嵴细胞迁移、增殖、分化和存活缺陷引起的肠道疾病。许多报道提出 miRNA 失调与 HSCR 的发生有关。然而,miRNA 的作用和机制尚未得到彻底研究。采用 qRT-PCR 和免疫组织化学分别检测 miR-92a 和 KLF4 的水平。通过 MTT、Transwell 和流式细胞术分别评估细胞活力、迁移和凋亡。双荧光素酶报告基因实验验证 miR-92a 与 KLF4 的结合关系。通过 Western blot 进一步确定 PI3K/AKT 信号水平。在此,发现 HSCR 组织中 miR-92a 表达升高,KLF4 表达降低,且表达模式呈负相关。miR-92a 的过表达抑制细胞活力和迁移,但促进细胞凋亡。然而,KLF4 的过表达则具有相反的效果。机制上,KLF4 是 miR-92a 的靶基因,通过激活 PI3K/AKT 信号通路来负调控生物学功能。这些结果证明,miR-92a 通过调节 KLF4/PI3K/AKT 轴抑制神经细胞的增殖和迁移。

相似文献

1
miR‑92a represses the viability and migration of nerve cells in Hirschsprung's disease by regulating the KLF4/PI3K/AKT pathway.miR-92a 通过调控 KLF4/PI3K/AKT 通路抑制先天性巨结肠症神经细胞的活力和迁移。
Acta Neurobiol Exp (Wars). 2022;82(3):336-346. doi: 10.55782/ane-2022-032.
2
miRNA Profiling Reveals Dysregulation of RET and RET-Regulating Pathways in Hirschsprung's Disease.微小RNA分析揭示先天性巨结肠症中RET及RET调控通路的失调
PLoS One. 2016 Mar 2;11(3):e0150222. doi: 10.1371/journal.pone.0150222. eCollection 2016.
3
Upregulation of MiR-369-3p suppresses cell migration and proliferation by targeting SOX4 in Hirschsprung's disease.在先天性巨结肠症中,MiR-369-3p的上调通过靶向SOX4抑制细胞迁移和增殖。
J Pediatr Surg. 2017 Aug;52(8):1363-1370. doi: 10.1016/j.jpedsurg.2017.04.002. Epub 2017 Apr 8.
4
Nidogen-1 is a common target of microRNAs MiR-192/215 in the pathogenesis of Hirschsprung's disease.在先天性巨结肠病的发病机制中,巢蛋白-1是微小RNA miR-192/215的共同靶点。
J Neurochem. 2015 Jul;134(1):39-46. doi: 10.1111/jnc.13118. Epub 2015 May 4.
5
Aberrant expression of LINC00346 regulates cell migration and proliferation via competitively binding to miRNA-148a-3p/Dnmt1 in Hirschsprung's disease.LINC00346 的异常表达通过与 miRNA-148a-3p/Dnmt1 竞争结合来调节先天性巨结肠病中的细胞迁移和增殖。
Pediatr Surg Int. 2022 Sep;38(9):1273-1281. doi: 10.1007/s00383-022-05144-9. Epub 2022 Jul 14.
6
miRNA‑92a inhibits vascular smooth muscle cell phenotypic modulation and may help prevent in‑stent restenosis.miRNA-92a 抑制血管平滑肌细胞表型调节,可能有助于预防支架内再狭窄。
Mol Med Rep. 2023 Feb;27(2). doi: 10.3892/mmr.2023.12927. Epub 2023 Jan 5.
7
Involvement of the lncRNA AFAP1-AS1/microRNA-195/E2F3 axis in proliferation and migration of enteric neural crest stem cells of Hirschsprung's disease.AFAP1-AS1/miR-195/E2F3 轴在先天性巨结肠症肠神经嵴干细胞增殖和迁移中的作用。
Exp Physiol. 2020 Nov;105(11):1939-1949. doi: 10.1113/EP088780. Epub 2020 Oct 7.
8
Long non-coding RNA FAL1 functions as a ceRNA to antagonize the effect of miR-637 on the down-regulation of AKT1 in Hirschsprung's disease.长链非编码 RNA FAL1 作为 ceRNA 发挥作用,拮抗 miR-637 对先天性巨结肠病中 AKT1 下调的作用。
Cell Prolif. 2018 Oct;51(5):e12489. doi: 10.1111/cpr.12489. Epub 2018 Jul 30.
9
SLIT2/ROBO1-miR-218-1-RET/PLAG1: a new disease pathway involved in Hirschsprung's disease.SLIT2/ROBO1-微小RNA-218-1-RET/PLAG1:一种参与先天性巨结肠病的新疾病途径。
J Cell Mol Med. 2015 Jun;19(6):1197-207. doi: 10.1111/jcmm.12454. Epub 2015 Mar 19.
10
LncRNA DRAIC regulates cell proliferation and migration by affecting the miR-34a-5p/ITGA6 signal axis in Hirschsprung's disease.长链非编码 RNA DRAIC 通过影响先天性巨结肠病中的 miR-34a-5p/ITGA6 信号轴来调节细胞增殖和迁移。
Ups J Med Sci. 2021 Aug 20;126. doi: 10.48101/ujms.v126.7895. eCollection 2021.

引用本文的文献

1
Pathogenic roles of microRNAs and competing endogenous RNAs in Hirschsprung disease (HSCR): Potential diagnostic markers for HSCR.微小RNA和竞争性内源性RNA在先天性巨结肠病(HSCR)中的致病作用:HSCR的潜在诊断标志物
Pediatr Discov. 2023 Jul 31;1(2):e21. doi: 10.1002/pdi3.21. eCollection 2023 Sep.
2
MicroRNA regulation of enteric nervous system development and disease.微小RNA对肠道神经系统发育及疾病的调控
Trends Neurosci. 2025 Apr;48(4):268-282. doi: 10.1016/j.tins.2025.02.004. Epub 2025 Mar 14.
3
Mechanisms Underlying the Stimulation of DUSP10/MKP5 Expression in Chondrocytes by High Molecular Weight Hyaluronic Acid.
高分子量透明质酸刺激软骨细胞中DUSP10/MKP5表达的潜在机制
Biomedicines. 2025 Feb 5;13(2):376. doi: 10.3390/biomedicines13020376.
4
Genetic association of with long-segment Hirschsprung's disease in southern Chinese children.与中国南方儿童长段先天性巨结肠症的基因关联。
Transl Pediatr. 2024 Aug 31;13(8):1395-1405. doi: 10.21037/tp-24-153. Epub 2024 Aug 28.
5
Analysis of the mechanism of alleviating Alzheimer's disease based on transcriptomics and proteomics.基于转录组学和蛋白质组学的阿尔茨海默病缓解机制分析
Korean J Physiol Pharmacol. 2024 Jul 1;28(4):361-377. doi: 10.4196/kjpp.2024.28.4.361.
6
The roles of non-coding RNAs in Hirschsprung's disease.非编码RNA在先天性巨结肠症中的作用。
Noncoding RNA Res. 2024 Feb 28;9(3):704-714. doi: 10.1016/j.ncrna.2024.02.015. eCollection 2024 Sep.
7
Sequencing Reveals miRNAs Enriched in the Developing Mouse Enteric Nervous System.测序揭示发育中的小鼠肠道神经系统中富集的微小RNA。
Noncoding RNA. 2023 Dec 22;10(1):1. doi: 10.3390/ncrna10010001.
8
A computational modeling of pri-miRNA expression.前体 miRNA 表达的计算建模。
PLoS One. 2024 Jan 2;19(1):e0290768. doi: 10.1371/journal.pone.0290768. eCollection 2024.
9
Non-coding RNAs are key players and promising therapeutic targets in atherosclerosis.非编码RNA是动脉粥样硬化的关键参与者和有前景的治疗靶点。
Front Cell Dev Biol. 2023 Sep 1;11:1237941. doi: 10.3389/fcell.2023.1237941. eCollection 2023.
10
Plasma exosomal miR-199a-3p downregulates cell proliferation and migration in Hirschsprung's disease by targeting mTOR.血浆外泌体 miR-199a-3p 通过靶向 mTOR 下调先天性巨结肠病中的细胞增殖和迁移。
Pediatr Surg Int. 2022 Dec 19;39(1):54. doi: 10.1007/s00383-022-05337-2.